Life sciences news roundup: Seagen expands; biotech vet Q&A; algae capsules for gut bug; more

This year’s Life Science Washington Innovation Northwest conference brought hundreds of researchers and entrepreneurs together over two days to discuss a wide range of science and biotech topics.

Among the many events, co-founders of Seattle-based company, Sana Therapeutics, Steve Harr and Hans Bishop, discussed the company going public last year with the largest IPO ever for a preclinical biotech company.

Life Science Washington’s CEO Marc Cummings also spoke to GeekWire on stage about strengthening the industry, bolstering its workforce and priorities in store for the trade organization.

READ THE STORY at GeekWire»